Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

P16 deletion and mutation analysis in human brain tumors 3rd Workshop on Biochemistry of NeuroEctodermal Tumours Barker, F. G., Chen, P. C., Furman, F., Aldape, K. D., Edwards, M. S., Israel, M. A. SPRINGER. 1997: 17–23

Abstract

We screened human primary and recurrent malignant glioma, juvenile pilocytic astrocytoma, medulloblastoma, and meningioma tissue specimens for alterations in p16 gene structure. Single strand conformation polymorphism (SSCP) analysis was used to screen for point mutations, and a quantitative polymerase chain reaction-based assay was used to screen for homozygous gene deletions. In malignant glioma specimens, homozygous p16 gene deletions were significantly more common in high-grade tumors than in low-grade gliomas. Point mutations causing alteration in predicted protein structure were not detected. Medulloblastomas showed rare homozygous deletions and no point mutations. No mutations were detected in meningiomas.

View details for Web of Science ID A1997WJ07400004

View details for PubMedID 9049826